ZFP161 promotes colorectal cancer progression by transcriptionally activating c-MYC.

Front Oncol · 2025 · PMC12956533 · PMID 41789397

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

Stage IV patients were strongly correlated with increased risk of death (HR = 20.68, 95% CI: 2.68–159.23, p = 0.004), whereas Stage II and Stage III patients showed a trend toward increased risk but did not reach statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.